"Tumor Hypoxia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hypoxic conditions in tumor cells due to the tumor outgrowing its blood supply. It is associated with increased METASTASIS and resistance to RADIOTHERAPY and DRUG THERAPY.
| Descriptor ID |
D000072258
|
| MeSH Number(s) |
G03.197.300.500 G04.270.300.500
|
| Concept/Terms |
Tumor Hypoxia- Tumor Hypoxia
- Hypoxia, Tumor
- Hypoxias, Tumor
- Tumor Hypoxias
- Tumor Cell Hypoxia
- Cell Hypoxia, Tumor
- Cell Hypoxias, Tumor
- Hypoxia, Tumor Cell
- Hypoxias, Tumor Cell
- Tumor Cell Hypoxias
|
Below are MeSH descriptors whose meaning is more general than "Tumor Hypoxia".
Below are MeSH descriptors whose meaning is more specific than "Tumor Hypoxia".
This graph shows the total number of publications written about "Tumor Hypoxia" by people in this website by year, and whether "Tumor Hypoxia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 4 | 6 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Hypoxia" by people in Profiles.
-
Hypoxia-Inducible Factor 2 Alpha (HIF2a) Inhibitors: Targeting Genetically Driven Tumor Hypoxia. Endocr Rev. 2023 03 04; 44(2):312-322.
-
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021 01 04; 20(1):7.
-
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches. Front Immunol. 2020; 11:573326.
-
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo. Cells. 2019 11 21; 8(12).
-
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy. Nat Metab. 2019 04; 1(4):431-444.
-
Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia. Mol Cancer Res. 2019 05; 17(5):1220-1232.
-
Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Rep. 2018 12 26; 25(13):3721-3732.e6.
-
18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer. PLoS One. 2018; 13(7):e0199970.
-
The tumour microenvironment links complement system dysregulation and hypoxic signalling?. Br J Radiol. 2019 Jan; 92(1093):20180069.
-
Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):816-831.